Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kenneth L Rosenthal

Showing results (31-40 of 42) with videos related to

Pageof 5
Sort By:
Scientific Reports|August 2, 2020
Expression profiling of human milk derived exosomal microRNAs and their targets in HIV-1 infected mothersMuhammad Atif Zahoor, Xiao-Dan Yao, Bethany M Henrick, et al.
Antiviral Research|December 27, 2005
Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848)Michael J McCluskie, Janna L M Cartier, Amy J Patrick, et al.
Nature Medicine|April 7, 2005
Vaccines in the public eyePaul Ritvo, Kumanan Wilson, Dennis Willms, et al.
AIDS Research and Human Retroviruses|December 18, 2003
Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responsesJonathan G Leith, David A Clark, Thomas J Matthews, et al.
AIDS Research and Human Retroviruses|December 9, 2004
Identification of mutations in proviral long terminal repeats of HIV type 1-infected subjects naive to drug therapyKaren F T Copeland, Zhaoxia Chen, Marnie Fiebig, et al.
Journal of Medical Virology|October 14, 2003
Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challengeDusan Sajic, Ali A Ashkar, Amy J Patrick, et al.
Plos One|January 10, 2013
Anti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cellsAnna G Drannik, Kakon Nag, Xiao-Dan Yao, et al.
AIDS (London, England)|March 22, 2008
Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infectionRichard T Lester, Xiao-Dan Yao, T Blake Ball, et al.
AIDS (London, England)|August 23, 2018
Breastfeeding mitigates the effects of maternal HIV on infant infectious morbidity in the Option B+ eraChristophe Toukam Tchakoute, Kristin Lynn Sainani, Sophia Osawe, et al.
Journal of Virology|February 21, 2012
Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cellsAnna G Drannik, Kakon Nag, Xiao-Dan Yao, et al.
Pageof 5

Showing results (31-40 of 42) with videos related to

Sort By:
Pageof 5
Scientific Reports|August 2, 2020
Expression profiling of human milk derived exosomal microRNAs and their targets in HIV-1 infected mothersMuhammad Atif Zahoor, Xiao-Dan Yao, Bethany M Henrick, et al.
Antiviral Research|December 27, 2005
Treatment of intravaginal HSV-2 infection in mice: a comparison of CpG oligodeoxynucleotides and resiquimod (R-848)Michael J McCluskie, Janna L M Cartier, Amy J Patrick, et al.
Nature Medicine|April 7, 2005
Vaccines in the public eyePaul Ritvo, Kumanan Wilson, Dennis Willms, et al.
AIDS Research and Human Retroviruses|December 18, 2003
Assessing human alloimmunization as a strategy for inducing HIV type 1 neutralizing anti-HLA responsesJonathan G Leith, David A Clark, Thomas J Matthews, et al.
AIDS Research and Human Retroviruses|December 9, 2004
Identification of mutations in proviral long terminal repeats of HIV type 1-infected subjects naive to drug therapyKaren F T Copeland, Zhaoxia Chen, Marnie Fiebig, et al.
Journal of Medical Virology|October 14, 2003
Parameters of CpG oligodeoxynucleotide-induced protection against intravaginal HSV-2 challengeDusan Sajic, Ali A Ashkar, Amy J Patrick, et al.
Plos One|January 10, 2013
Anti-HIV-1 activity of elafin depends on its nuclear localization and altered innate immune activation in female genital epithelial cellsAnna G Drannik, Kakon Nag, Xiao-Dan Yao, et al.
AIDS (London, England)|March 22, 2008
Toll-like receptor expression and responsiveness are increased in viraemic HIV-1 infectionRichard T Lester, Xiao-Dan Yao, T Blake Ball, et al.
AIDS (London, England)|August 23, 2018
Breastfeeding mitigates the effects of maternal HIV on infant infectious morbidity in the Option B+ eraChristophe Toukam Tchakoute, Kristin Lynn Sainani, Sophia Osawe, et al.
Journal of Virology|February 21, 2012
Anti-HIV-1 activity of elafin is more potent than its precursor's, trappin-2, in genital epithelial cellsAnna G Drannik, Kakon Nag, Xiao-Dan Yao, et al.
Pageof 5